Company Pharma Dacica Plus Srl with Fiscal Code 29490113
recorded a turnover of 2024 of
45.714,
with a net profit of
-17.877
and having an average number of employees of
- .
The company operates in the field of Fabricarea altor produse alimentare n.c.a. having the NACE code 1089.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Pharma Dacica Plus Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
49.426
46.694
88.183
122.570
123.758
86.683
103.263
119.941
66.506
45.714
Total Income - EUR
53.525
45.245
85.446
124.440
122.125
85.264
103.451
113.400
47.274
34.130
Total Expenses - EUR
44.437
39.069
52.566
103.288
95.139
67.832
73.086
98.853
56.727
52.007
Gross Profit/Loss - EUR
9.088
6.176
32.880
21.152
26.986
17.432
30.365
14.546
-9.453
-17.877
Net Profit/Loss - EUR
7.605
5.156
31.998
19.927
25.974
16.594
29.456
13.371
-10.118
-17.877
Employees
1
1
2
0
5
3
0
3
1
0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -30.9%, from 66.506 euro in the year 2023, to 45.714 euro in 2024.
Check the financial reports for the company - Pharma Dacica Plus Srl
Financial Rating - PHARMA DACICA PLUS SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Pharma Dacica Plus Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Pharma Dacica Plus Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Pharma Dacica Plus Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Pharma Dacica Plus Srl - CUI 29490113
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
0
0
0
46
45
44
43
0
57.654
45.470
Current Assets
40.873
62.172
100.080
118.556
102.311
91.192
111.829
62.784
45.586
37.818
Inventories
19.834
19.117
16.707
18.880
17.555
14.150
18.918
7.972
7.108
9.395
Receivables
20.982
41.454
66.252
65.518
84.728
70.901
72.552
53.155
35.709
19.706
Cash
57
1.601
17.121
34.157
28
6.141
20.359
1.658
2.768
8.717
Shareholders Funds
-1.407
3.763
32.042
51.422
26.048
31.268
54.711
13.420
3.261
-25.525
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
42.280
58.409
68.039
67.180
76.764
60.416
57.161
49.365
100.405
108.822
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"1089 - 1089"
CAEN Financial Year
1089
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
37.818 euro in 2024 which includes Inventories of
9.395 euro, Receivables of
19.706 euro and cash availability of
8.717 euro.
The company's Equity was valued at
-25.525 euro, while total Liabilities amounted to
108.822 euro.
Equity decreased by -28.768 euro, from 3.261 euro in 2023, to -25.525 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Pharma Dacica Plus Srl